TABLE 2.
Enterovirus subgroups determined by DNA sequencing analysis in nasopharyngeal swab specimens that were positive for human enterovirus/rhinovirus by RP assay
| Organisma | No. (%) of positive specimens (n = 194)b |
||
|---|---|---|---|
| 2013 (n = 20) | 2014 (n = 174) | Total (n = 194) | |
| Enterovirus | |||
| EV-D68 | 0 | 72 (41.4) | 72 (37.1) |
| Coxsackievirus | 0 | 4 (2.3) | 4 (2.1) |
| Echovirus | 1 (5.0) | 3 (1.7) | 4 (2.1) |
| Enterovirus 71 | 0 | 1 (0.6) | 1 (0.5) |
| Rhinovirus | |||
| HRV-A | 5 (25.0) | 23 (13.2) | 28 (14.4) |
| HRV-B | 4 (20.0) | 24 (13.8) | 28 (14.4) |
| HRV-C | 10 (50.0) | 47 (27.0) | 57 (29.4) |
| Total | 20 | 174 (100) | 194 (100) |
a
HRV-A, human rhinovirus A; HRV-B, human rhinovirus B; HRV-C, human rhinovirus C.
b
Results included 20 of 25 NP specimens (2013) and 174 of 260 NP specimens (2014) examined by both rRT-PCR and DNA sequencing analysis.